Equillium (EQ) Cash from Investing Activities (2018 - 2026)
Equillium (EQ) reported Cash from Investing Activities of -$3000.0 for Q1 2026, down 100.07% year-over-year from $4.5 million in Q1 2025, and up 90.62% on a QoQ basis from -$32000.0 in Q4 2025.
Equillium (EQ) has 9 years of Cash from Investing Activities data on file, last reported at -$3000.0 in Q1 2026.
- Quarterly Cash from Investing Activities fell 100.07% year-over-year to -$3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$35000.0 (down 100.17% YoY) and the FY2025 annual result came in at $4.5 million, down 67.68% from the prior year.
- Cash from Investing Activities climbed to -$3000.0 in Q1 2026 per EQ's latest filing, from -$32000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $15.0 million in Q3 2022 and bottomed at -$25.2 million in Q1 2023.
- The 5-year median for Cash from Investing Activities is $4.5 million (2025), against an average of $2.1 million.
- The widest annual swing landed in 2022, when Cash from Investing Activities plunged 346.6%; it then soared 258.81% in 2025.
- Tracing EQ's Cash from Investing Activities over 5 years: stood at $7.0 million in 2022, then sank by 179.76% to -$5.6 million in 2023, then jumped by 207.73% to $6.0 million in 2024, then plunged by 100.53% to -$32000.0 in 2025, then surged by 90.62% to -$3000.0 in 2026.
- Per Business Quant, the three latest EQ Cash from Investing Activities figures stand at -$3000.0 (Q1 2026), -$32000.0 (Q4 2025), and $4.5 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Equillium | 279.21 Mn | 218.82 Mn | - | -3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Mar 31, 2025 | 4.50 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Dec 31, 2024 | 6.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Sep 30, 2024 | 12.00 Mn |
| Jun 30, 2024 | -1.35 Mn |
| Jun 30, 2024 | -1.35 Mn |
| Mar 31, 2024 | -2.83 Mn |
| Mar 31, 2024 | -2.83 Mn |
| Dec 31, 2023 | -5.57 Mn |
| Dec 31, 2023 | -5.57 Mn |
| Sep 30, 2023 | 10.99 Mn |
| Sep 30, 2023 | 10.99 Mn |
| Jun 30, 2023 | 15.00 Mn |
| Jun 30, 2023 | 15.00 Mn |
| Mar 31, 2023 | -25.18 Mn |
| Mar 31, 2023 | -25.18 Mn |
| Dec 31, 2022 | 6.98 Mn |
| Dec 31, 2022 | 6.98 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Jun 30, 2022 | 8.69 Mn |
| Jun 30, 2022 | 8.69 Mn |
| Mar 31, 2022 | -11.99 Mn |
| Mar 31, 2022 | -11.99 Mn |
| Dec 31, 2021 | -16.89 Mn |
| Dec 31, 2021 | -16.89 Mn |
| Sep 30, 2021 | 10.47 Mn |
| Sep 30, 2021 | 10.47 Mn |
| Jun 30, 2021 | 28.97 Mn |
| Jun 30, 2021 | 28.97 Mn |
| Mar 31, 2021 | 4.86 Mn |
| Mar 31, 2021 | 4.86 Mn |
| Dec 31, 2020 | -17.04 Mn |
| Dec 31, 2020 | -17.04 Mn |
| Sep 30, 2020 | -23.02 Mn |
| Sep 30, 2020 | -23.02 Mn |
| Jun 30, 2020 | 8.46 Mn |
| Jun 30, 2020 | 8.46 Mn |
| Mar 31, 2020 | 13.01 Mn |
| Mar 31, 2020 | 13.01 Mn |
| Dec 31, 2019 | -5.33 Mn |
| Dec 31, 2019 | -5.33 Mn |
| Sep 30, 2019 | -225,000.00 |
| Sep 30, 2019 | -225,000.00 |
| Jun 30, 2019 | 6.04 Mn |
| Jun 30, 2019 | 6.04 Mn |
| Mar 31, 2019 | -2.65 Mn |
| Mar 31, 2019 | -2.65 Mn |
| Dec 31, 2018 | -37.41 Mn |
| Dec 31, 2018 | -37.41 Mn |
| Sep 30, 2018 | -3,000.00 |
| Sep 30, 2018 | -3,000.00 |
| Jun 30, 2018 | -17,000.00 |
| Jun 30, 2018 | -17,000.00 |
| Mar 31, 2018 | -5,000.00 |
| Mar 31, 2018 | -5,000.00 |